Armistice Capital LLC Increases Stock Holdings in AngioDynamics, Inc. $ANGO

Armistice Capital LLC lifted its position in AngioDynamics, Inc. (NASDAQ:ANGO) by 3.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,700,000 shares of the medical instruments supplier’s stock after purchasing an additional 64,000 shares during the quarter. Armistice Capital LLC’s holdings in AngioDynamics were worth $21,828,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Divisadero Street Capital Management LP grew its holdings in shares of AngioDynamics by 8.3% in the third quarter. Divisadero Street Capital Management LP now owns 3,678,125 shares of the medical instruments supplier’s stock valued at $41,085,000 after purchasing an additional 282,695 shares during the period. Millennium Management LLC grew its holdings in shares of AngioDynamics by 28.1% in the third quarter. Millennium Management LLC now owns 1,793,152 shares of the medical instruments supplier’s stock valued at $20,030,000 after purchasing an additional 393,682 shares during the period. Kotler Kevin purchased a new stake in shares of AngioDynamics in the fourth quarter valued at about $21,997,000. Weber Capital Management LLC ADV purchased a new stake in shares of AngioDynamics in the fourth quarter valued at about $17,978,000. Finally, Nuveen LLC boosted its stake in AngioDynamics by 40.5% during the fourth quarter. Nuveen LLC now owns 1,295,072 shares of the medical instruments supplier’s stock worth $16,629,000 after buying an additional 373,110 shares during the period. Hedge funds and other institutional investors own 89.43% of the company’s stock.

AngioDynamics Stock Performance

NASDAQ ANGO opened at $11.74 on Thursday. The firm has a 50 day simple moving average of $11.21 and a 200-day simple moving average of $11.38. AngioDynamics, Inc. has a one year low of $8.36 and a one year high of $13.99. The firm has a market cap of $485.10 million, a price-to-earnings ratio of -15.65 and a beta of 0.38.

AngioDynamics (NASDAQ:ANGO) last posted its quarterly earnings data on Thursday, April 2nd. The medical instruments supplier reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.04. AngioDynamics had a negative net margin of 10.01% and a negative return on equity of 4.66%. The business had revenue of $78.42 million during the quarter, compared to analyst estimates of $76.77 million. Equities analysts predict that AngioDynamics, Inc. will post -0.19 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ANGO has been the subject of several research analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of AngioDynamics in a research note on Monday, April 20th. Canaccord Genuity Group lowered their target price on shares of AngioDynamics from $18.00 to $16.00 and set a “buy” rating for the company in a research note on Monday, April 6th. Freedom Capital raised shares of AngioDynamics to a “strong-buy” rating in a research note on Monday, April 6th. Finally, Zacks Research lowered shares of AngioDynamics from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, AngioDynamics has an average rating of “Moderate Buy” and an average price target of $18.67.

AngioDynamics Company Profile

AngioDynamics, Inc is a medical technology company headquartered in Latham, New York, that develops, manufactures and markets a broad range of minimally invasive medical devices. The company’s products focus on three core areas: vascular access, peripheral vascular intervention and interventional oncology. Its solutions are designed to improve procedural outcomes, reduce complications and enhance patient comfort in hospital and outpatient settings.

In the vascular access segment, AngioDynamics offers a portfolio of devices including implanted ports, peripherally inserted central catheters (PICCs), hemodialysis catheters and specialty blood management products.